Hyperviscosity syndrome in COVID-19 and related vaccines: exploring of uncertainties

Hayder M Al-Kuraishy1, Ali I Al-Gareeb1, Maisra M El-Bouseary2

  • 1Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq.

Insights

Hyperviscosity syndrome (HVS) is linked to COVID-19 and vaccines, especially in those with prior infection or metabolic issues. Increased fibrinogen and immunoglobulins may cause HVS, but more research is needed to confirm causality.

Area of Science:

  • Internal Medicine
  • Immunology
  • Cardiology

Background:

  • Hyperviscosity syndrome (HVS) is a recognized complication of viral infections.
  • COVID-19 and its vaccines have been anecdotally linked to HVS development.
  • HVS can lead to significant cardiovascular and neurological complications.

Purpose of the Study:

  • To critically review and establish the association between COVID-19, COVID-19 vaccines, and the development of HVS.
  • To explore the potential mechanisms underlying HVS in the context of COVID-19 and vaccination.

Main Methods:

  • Critical review of existing literature.
  • Analysis of immunological and hematological factors potentially contributing to HVS.
  • Examination of clinical outcomes associated with HVS in COVID-19 patients.

Main Results:

  • COVID-19 can increase blood viscosity (BV) by altering fibrinogen, albumin, lipoproteins, and RBC indices.
  • HVS in COVID-19 is associated with cardiovascular events (MI, stroke) and reduced tissue oxygenation, potentially contributing to long COVID.
  • HVS may occur in vaccine recipients, particularly those with prior COVID-19 or metabolic syndrome, due to elevated immunoglobulin levels.

Conclusions:

  • COVID-19 and its vaccines are associated with HVS, especially in individuals with prior infection and metabolic derangements.
  • Elevated fibrinogen and immunoglobulins are proposed mechanisms for HVS, with dehydration, oxidative stress, and inflammation as contributing factors.
  • Further prospective and retrospective studies are required to definitively establish a causal relationship between COVID-19/vaccines and HVS.

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
46
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
49
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
302
Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
156
Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
18.6K